Abstract
The large volume of preclinical investigations begets the question of whether to proceed with clinical trials in preconditioning for neurological disorders, particularly for treatment of human cerebral ischemia. This important question was discussed during the 2nd Translational Preconditioning Meeting held at the University of Miami. While recommendations for proceeding to clinical trials have been devised in other fields of stroke therapy, such as neuroprotection, no such guidelines exist for preconditioning. During the discussion, the general opinion was to proceed with clinical preconditioning trials, with the understanding that initial trials be exploratory in nature and focus on the development of biomarkers, assessing the elicitability of the preconditioning response.
Similar content being viewed by others
References
Koch S, Sacco RL, Perez-Pinzon MA. Preconditioning the brain: moving on to the next frontier of neurotherapeutics. Stroke. 2012;43:1455–7.
Dirnagl U, Fisher M. International, multicenter randomized preclinical trials in translational stroke research: it's time to act. J Cereb Blood Flow Metab. 2012;32:933–5.
Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40:2244–50.
Koch S. Preconditioning the human brain: practical considerations for proving cerebral protection. Transl Stroke Res. 2010;1:161–9.
Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370:575–9.
Ali N, Rizwi F, Iqbal A, Rashid A. Induced remote ischemic pre-conditioning on ischemia–reperfusion injury in patients undergoing coronary artery bypass. J Coll Physicians Surg Pak. 2010;20:427–31.
Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, et al. Cardiac remote ischemic preconditioning in coronary stenting (crisp stent) study: a prospective, randomized control trial. Circulation. 2009;119:820–7.
Hong DM, Mint JJ, Kim JH, Sohn IS, Lim TW, Lim YJ, et al. The effect of remote ischaemic preconditioning on myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery. Anaesth Intensive Care. 2010;38:924–9.
Li L, Luo W, Huang L, Zhang W, Gao Y, Jiang H, et al. Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial. J Surg Res. 2010;164:e21–6.
Rahman IA, Mascaro JG, Steeds RP, Frenneaux MP, Nightingale P, Gosling P, et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation. 2010;122:S53–9.
Walsh SR, Nouraei SA, Tang TY, Sadat U, Carpenter RH, Gaunt ME. Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomized clinical trial. Vasc Endovascular Surg. 2010;44:434–9.
Koch S, Katsnelson M, Dong C, Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke. 2011;42:1387–91.
Gonzalez NR, Hamilton R, Bilgin-Freiert A, Dusick J, Vespa P, Hu X, et al. Cerebral hemodynamic and metabolic effects of remote ischemic preconditioning in patients with subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:193–8.
Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106:2881–3.
Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation. 2007;116:I98–I105.
Della Morte D, Abete P, Gallucci F, Scaglione A, D’Ambrosio D, Gargiulo G, et al. Transient ischemic attack before nonlacunar ischemic stroke in the elderly. J Stroke Cerebrovasc Dis. 2008;17:257–62.
Kocsis GF, Pipis J, Fekete V, Kovacs-Simon A, Odendaal L, Molnar E, et al. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts. Am J Physiol Heart Circ Physiol. 2008;294:H2406–9.
Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 2003;362:1028–37.
Warzecha Z, Dembinski A, Ceranowicz P, Dembinski M, Cieszkowski J, Kusnierz-Cabala B, et al. Influence of ischemic preconditioning on blood coagulation, fibrinolytic activity and pancreatic repair in the course of caerulein-induced acute pancreatitis in rats. J Physiol Pharmacol. 2007;58:303–19.
Lund SS. Ischaemic conditioning for myocardial salvage after ami. Lancet. 2010;375:1691–2. author reply 1692.
Knudsen AR, Kannerup AS, Gronbaek H, Andersen KJ, Funch-Jensen P, Frystyk J, et al. Effects of ischemic pre- and postconditioning on Hif-1alpha, VEGF and TGF-beta expression after warm ischemia and reperfusion in the rat liver. Comp Hepatol. 2011;10:3.
Szabo A, Varga R, Keresztes M, Vizler C, Nemeth I, Razga Z, et al. Ischemic limb preconditioning downregulates systemic inflammatory activation. J Orthop Res. 2009;27:897–902.
Valtchanova-Matchouganska A, Gondwe M, Nadar A. C-reactive protein in acute and delayed preconditioning of the rat heart. Cardiovasc J S Afr. 2005;16:118–23.
Zhang FY, Chen XC, Ren HM, Bao WM. Effects of ischemic preconditioning on blood–brain barrier permeability and mmp-9 expression of ischemic brain. Neurol Res. 2006;28:21–4.
Lalu MM, Csonka C, Giricz Z, Csont T, Schulz R, Ferdinandy P. Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2. Biochem Biophys Res Commun. 2002;296:937–41.
Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, et al. Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a k(atp)-channel dependent mechanism. Circulation. 2007;116:1386–95.
Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MMH, Cherepanov V, et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics. 2004;19:143–50.
Zhou W, Zeng D, Chen R, Liu J, Yang G, Liu P, et al. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol. 2010;31:22–9.
Castillo J, Moro MA, Blanco M, Leira R, Serena J, Lizasoain I, et al. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Ann Neurol. 2003;54:811–9.
Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, et al. Sevoflurane preconditioning at 1 mac only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth. 2007;99:624–31.
Meco M, Cirri S, Gallazzi C, Magnani G, Cosseta D. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study. Eur J Cardiothorac Surg. 2007;32:319–25.
Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, et al. Resveratrol and ischemic preconditioning in the brain. Curr Med Chem. 2008;15:1545–51.
Conflict of interest
I have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koch, S. Moving Towards Preconditioning for Neurological Disorders: Are We Ready for Clinical Trials?. Transl. Stroke Res. 4, 15–18 (2013). https://doi.org/10.1007/s12975-012-0220-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-012-0220-7